Fresenius Medical Care AG & Co. KGaA (FMCQF)
USD 46.12
(-2.91%)
USD 46.12
(-2.91%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 19.45 Billion EUR | -6.28% |
| 2022 | 20.75 Billion EUR | 3.66% |
| 2021 | 20.02 Billion EUR | -8.38% |
| 2020 | 21.85 Billion EUR | 11.43% |
| 2019 | 19.61 Billion EUR | 18.54% |
| 2018 | 16.54 Billion EUR | -6.95% |
| 2017 | 17.78 Billion EUR | 7.33% |
| 2016 | 16.56 Billion EUR | 1.06% |
| 2015 | 16.39 Billion EUR | 25.94% |
| 2014 | 13.01 Billion EUR | 23.05% |
| 2013 | 10.58 Billion EUR | 1.39% |
| 2012 | 10.43 Billion EUR | 5.7% |
| 2011 | 9.87 Billion EUR | 8.93% |
| 2010 | 9.06 Billion EUR | 15.45% |
| 2009 | 7.85 Billion EUR | 2.98% |
| 2008 | 7.62 Billion EUR | 14.35% |
| 2007 | 6.66 Billion EUR | 3.53% |
| 2006 | 6.43 Billion EUR | 12.63% |
| 2005 | 5.71 Billion EUR | 24.45% |
| 2004 | 4.59 Billion EUR | 4.68% |
| 2003 | 4.38 Billion EUR | -9.41% |
| 2002 | 4.84 Billion EUR | -11.29% |
| 2001 | 5.46 Billion EUR | 22.09% |
| 2000 | 4.47 Billion EUR | 17.21% |
| 1999 | 3.81 Billion EUR | 27.68% |
| 1998 | 2.98 Billion EUR | 0.94% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.76 Billion EUR | 0.88% |
| 2024 Q1 | 4.72 Billion EUR | -5.27% |
| 2023 Q3 | 5.21 Billion USD | -0.86% |
| 2023 Q1 | 5.09 Billion USD | -4.67% |
| 2023 Q2 | 5.26 Billion USD | 3.23% |
| 2023 Q4 | 5.5 Billion EUR | 5.51% |
| 2023 FY | 19.45 Billion EUR | -6.28% |
| 2022 FY | 20.75 Billion EUR | 3.66% |
| 2022 Q4 | 5.34 Billion EUR | 7.08% |
| 2022 Q3 | 4.99 Billion EUR | 5.0% |
| 2022 Q2 | 4.75 Billion EUR | 4.58% |
| 2022 Q1 | 4.54 Billion EUR | -2.12% |
| 2021 Q1 | 4.94 Billion EUR | 12.45% |
| 2021 Q4 | 4.64 Billion EUR | 4.63% |
| 2021 Q3 | 4.44 Billion EUR | 2.81% |
| 2021 Q2 | 4.32 Billion EUR | -12.69% |
| 2021 FY | 20.02 Billion EUR | -8.38% |
| 2020 Q1 | 4.48 Billion EUR | -2.01% |
| 2020 Q3 | 4.41 Billion EUR | -3.14% |
| 2020 Q4 | 4.4 Billion EUR | -0.31% |
| 2020 FY | 21.85 Billion EUR | 11.43% |
| 2020 Q2 | 4.55 Billion EUR | 1.54% |
| 2019 FY | 19.61 Billion EUR | 18.54% |
| 2019 Q3 | 4.41 Billion EUR | 1.7% |
| 2019 Q4 | 4.57 Billion EUR | 3.64% |
| 2019 Q2 | 4.34 Billion EUR | 5.14% |
| 2019 Q1 | 4.13 Billion EUR | -3.89% |
| 2018 Q4 | 4.29 Billion EUR | 5.96% |
| 2018 Q1 | 3.97 Billion EUR | -10.22% |
| 2018 Q2 | 4.21 Billion EUR | 5.98% |
| 2018 Q3 | 4.05 Billion EUR | -3.7% |
| 2018 FY | 16.54 Billion EUR | -6.95% |
| 2017 Q3 | 4.33 Billion EUR | -3.03% |
| 2017 FY | 17.78 Billion EUR | 7.33% |
| 2017 Q1 | 4.54 Billion EUR | -13.25% |
| 2017 Q2 | 4.47 Billion EUR | -1.7% |
| 2017 Q4 | 4.42 Billion EUR | 2.15% |
| 2016 FY | 16.56 Billion EUR | 1.06% |
| 2016 Q3 | 4.09 Billion EUR | 3.14% |
| 2016 Q1 | 3.71 Billion EUR | -13.66% |
| 2016 Q4 | 5.24 Billion EUR | 27.92% |
| 2016 Q2 | 3.97 Billion EUR | 7.1% |
| 2015 Q1 | 3.65 Billion EUR | -7.37% |
| 2015 FY | 16.39 Billion EUR | 25.94% |
| 2015 Q4 | 4.29 Billion EUR | 14.29% |
| 2015 Q3 | 3.76 Billion EUR | 0.45% |
| 2015 Q2 | 3.74 Billion EUR | 2.37% |
| 2014 Q3 | 3.24 Billion EUR | 15.31% |
| 2014 FY | 13.01 Billion EUR | 23.05% |
| 2014 Q4 | 3.94 Billion EUR | 21.79% |
| 2014 Q2 | 2.81 Billion EUR | 8.48% |
| 2014 Q1 | 2.59 Billion EUR | -1.07% |
| 2013 Q4 | 2.61 Billion EUR | -3.6% |
| 2013 FY | 10.58 Billion EUR | 1.39% |
| 2013 Q3 | 2.71 Billion EUR | -2.16% |
| 2013 Q2 | 2.77 Billion EUR | 2.66% |
| 2013 Q1 | 2.7 Billion EUR | 5.12% |
| 2012 Q2 | 2.7 Billion EUR | 11.18% |
| 2012 Q4 | 2.57 Billion EUR | -3.34% |
| 2012 Q3 | 2.66 Billion EUR | -1.69% |
| 2012 Q1 | 2.43 Billion EUR | -15.95% |
| 2012 FY | 10.43 Billion EUR | 5.7% |
| 2011 Q1 | 2.15 Billion EUR | -15.41% |
| 2011 Q4 | 2.89 Billion EUR | 21.39% |
| 2011 Q2 | 2.2 Billion EUR | 2.59% |
| 2011 Q3 | 2.38 Billion EUR | 8.19% |
| 2011 FY | 9.87 Billion EUR | 8.93% |
| 2010 FY | 9.06 Billion EUR | 15.45% |
| 2010 Q1 | 2.14 Billion EUR | -4.26% |
| 2010 Q4 | 2.54 Billion EUR | 13.3% |
| 2010 Q3 | 2.24 Billion EUR | -7.19% |
| 2010 Q2 | 2.41 Billion EUR | 12.62% |
| 2009 Q2 | 1.96 Billion EUR | 2.09% |
| 2009 Q1 | 1.92 Billion EUR | -4.81% |
| 2009 FY | 7.85 Billion EUR | 2.98% |
| 2009 Q4 | 2.24 Billion EUR | 13.67% |
| 2009 Q3 | 1.97 Billion EUR | 0.15% |
| 2008 Q2 | 1.69 Billion EUR | 6.49% |
| 2008 FY | 7.62 Billion EUR | 14.35% |
| 2008 Q1 | 1.59 Billion EUR | -3.94% |
| 2008 Q3 | 1.92 Billion EUR | 13.63% |
| 2008 Q4 | 2.02 Billion EUR | 5.32% |
| 2007 Q4 | 1.65 Billion EUR | -2.62% |
| 2007 Q2 | 1.77 Billion EUR | 2.24% |
| 2007 FY | 6.66 Billion EUR | 3.53% |
| 2007 Q1 | 1.73 Billion EUR | 8.82% |
| 2007 Q3 | 1.7 Billion EUR | -4.28% |
| 2006 Q1 | 1.44 Billion EUR | -7.73% |
| 2006 Q4 | 1.59 Billion EUR | -9.33% |
| 2006 Q3 | 1.76 Billion EUR | 3.89% |
| 2006 FY | 6.43 Billion EUR | 12.63% |
| 2006 Q2 | 1.69 Billion EUR | 17.58% |
| 2005 FY | 5.71 Billion EUR | 24.45% |
| 2005 Q4 | 1.56 Billion EUR | 9.47% |
| 2005 Q1 | 1.24 Billion EUR | 37.2% |
| 2005 Q3 | 1.42 Billion EUR | 3.23% |
| 2005 Q2 | 1.38 Billion EUR | 11.37% |
| 2004 Q2 | 1.27 Billion EUR | 7.46% |
| 2004 FY | 4.59 Billion EUR | 4.68% |
| 2004 Q4 | 904.71 Million EUR | -28.64% |
| 2004 Q1 | 1.18 Billion EUR | 32.59% |
| 2004 Q3 | 1.26 Billion EUR | -0.37% |
| 2003 Q1 | 1.18 Billion EUR | 10.98% |
| 2003 Q3 | 1.2 Billion EUR | 1.83% |
| 2003 FY | 4.38 Billion EUR | -9.41% |
| 2003 Q4 | 893.2 Million EUR | -26.13% |
| 2003 Q2 | 1.18 Billion EUR | -0.16% |
| 2002 FY | 4.84 Billion EUR | -11.29% |
| 2002 Q3 | 1.3 Billion EUR | 3.1% |
| 2002 Q2 | 1.26 Billion EUR | -7.25% |
| 2002 Q1 | 1.36 Billion EUR | -10.55% |
| 2002 Q4 | 1.07 Billion EUR | -17.67% |
| 2001 Q4 | 1.52 Billion EUR | 12.89% |
| 2001 Q2 | 1.41 Billion EUR | 6.79% |
| 2001 FY | 5.46 Billion EUR | 22.09% |
| 2001 Q1 | 1.32 Billion EUR | 41.23% |
| 2001 Q3 | 1.34 Billion EUR | -4.62% |
| 2000 Q1 | 1.04 Billion EUR | -6.72% |
| 2000 Q4 | 937.22 Million EUR | -23.53% |
| 2000 Q3 | 1.22 Billion EUR | 12.58% |
| 2000 Q2 | 1.08 Billion EUR | 3.96% |
| 2000 FY | 4.47 Billion EUR | 17.21% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 FY | 3.81 Billion EUR | 27.68% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q1 | 891.88 Million EUR | 11.96% |
| 1999 Q4 | 1.12 Billion EUR | 25.02% |
| 1998 Q4 | 796.62 Million EUR | 5.45% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | 2.98 Billion EUR | 0.94% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | 2.96 Billion EUR | 0.0% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| The Amacore Group, Inc. | 28.82 Million USD | -67377.339% |
| Arem Pacific Corporation | 343.47 Thousand USD | -5663599.091% |
| Assisted 4 Living, Inc. | 880.78 Thousand USD | -2208575.586% |
| BioCorRx Inc. | 89.16 Thousand USD | -21818671.871% |
| Bionik Laboratories Corp. | 1.8 Million USD | -1077542.114% |
| Banyan Corp. | 5 Million USD | -388685.416% |
| Clearday, Inc. | 12.48 Million USD | -155671.61% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -599209.89% |
| Quantum Medical Transport, Inc. | 1310.14 USD | -1484850145.012% |
| Empower Clinics Inc. | 4.66 Million USD | -417223.022% |
| First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -64877728.914% |
| Selectis Health, Inc. | 36.78 Million USD | -52787.454% |
| Ethema Health Corporation | 5.34 Million USD | -363860.792% |
| HealthLynked Corp. | 5.72 Million USD | -339856.808% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.24 Million USD | -210237.024% |
| JRSIS Health Care Corporation | 3.46 Million USD | -561829.333% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 453.75 Million USD | -4187.266% |
| MedSmart Group Inc. | - USD | -Infinity% |
| North America Frac Sand, Inc. | 137.3 Thousand USD | -14168078.144% |
| Nova Leap Health Corp. | 26.17 Million USD | -74209.937% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -5531791.897% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -185142.833% |
| Raffles Medical Group Ltd | 536.52 Million USD | -3525.847% |
| Ryman Healthcare Limited | 650.53 Million USD | -2890.407% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 4.61 Million USD | -421561.275% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
| Veltex Corporation | 838.65 Thousand USD | -2319523.707% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 1.12 Million USD | -1733602.616% |